These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6151589)

  • 21. Catecholaminergic neurons in the ventrolateral medulla and nucleus of the solitary tract in the human.
    Arango V; Ruggiero DA; Callaway JL; Anwar M; Mann JJ; Reis DJ
    J Comp Neurol; 1988 Jul; 273(2):224-40. PubMed ID: 2901439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
    Kastner A; Hirsch EC; Herrero MT; Javoy-Agid F; Agid Y
    J Neurochem; 1993 Sep; 61(3):1024-34. PubMed ID: 8103078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
    Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two types of spheroid bodies in the nigral neurons in Parkinson's disease.
    Yamada T; Akiyama H; McGeer PL
    Can J Neurol Sci; 1991 Aug; 18(3):287-94. PubMed ID: 1913362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus.
    Swanson LW; Sawchenko PE; Bérod A; Hartman BK; Helle KB; Vanorden DE
    J Comp Neurol; 1981 Feb; 196(2):271-85. PubMed ID: 6111572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.
    Chan-Palay V; Asan E
    J Comp Neurol; 1989 Sep; 287(3):373-92. PubMed ID: 2570794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.
    Kingsbury AE; Bandopadhyay R; Silveira-Moriyama L; Ayling H; Kallis C; Sterlacci W; Maeir H; Poewe W; Lees AJ
    Mov Disord; 2010 Nov; 25(15):2508-15. PubMed ID: 20818670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of dopamine-containing neurons and fibres in the feline medulla oblongata: a comparative study using catecholamine-synthesizing enzyme and dopamine immunohistochemistry.
    Maqbool A; Batten TF; Berry PA; McWilliam PN
    Neuroscience; 1993 Apr; 53(3):717-33. PubMed ID: 8098139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
    Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.
    Halliday GM; Li YW; Blumbergs PC; Joh TH; Cotton RG; Howe PR; Blessing WW; Geffen LB
    Ann Neurol; 1990 Apr; 27(4):373-85. PubMed ID: 1972319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain.
    Nagatsu T; Kato T; Numata Y; Ikuta K; Sano M
    Clin Chim Acta; 1977 Mar; 75(2):221-32. PubMed ID: 14798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal cord lesions in sporadic Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
    Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
    Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distributions of tyrosine hydroxylase-, dopamine-beta-hydroxylase-, and phenylethanolamine-N-methyltransferase-immunoreactive neurons in the brain of the hamster (Mesocricetus auratus).
    Vincent SR
    J Comp Neurol; 1988 Feb; 268(4):584-99. PubMed ID: 2895779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neocortical changes in Parkinson's disease, revisited.
    Sugiyama H; Hainfellner JA; Yoshimura M; Budka H
    Clin Neuropathol; 1994; 13(2):55-9. PubMed ID: 8205726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.
    Malessa S; Hirsch EC; Cervera P; Duyckaerts C; Agid Y
    Neurology; 1990 Nov; 40(11):1739-43. PubMed ID: 1978260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
    Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
    Am J Pathol; 1996 May; 148(5):1517-29. PubMed ID: 8623921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.